Contributed by:
This grant was established in 2019.
Research Grants Supported
Sonia Vallabh, PhD, 2020
Broad Institute of MIT and Harvard
“Assessing efficacy of zinc-finger repressors of prion protein as a therapeutic for prion disease”
Steven E. Arnold, MD, 2019
Assessing long-term stability of cerebrospinal fluid PrP levels in genetic prion disease mutation carriers
Professor of Neurology, Harvard Medical School; and Translational Neurology Head of the Interdisciplinary Brain Center, Massachusetts General Hospital
Roberto Chiesa, PhD, 2019
Nanoparticle-mediated brain delivery of a tetracationic porphyrin with potent anti-prion activities
Laboratory of Prion Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
Dr. Graham S. Jackson, 2019
Development of a quantitative, real-time Protein-Misfolding by Cyclic Amplification (PMCA) reaction
Medical Research Council (MRC) Prion Unit at University College London
Jiyan Ma, PhD, 2019
Determining the therapeutic potential of anti-PrP nanobody
Professor, Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI
Gustavo Mostoslavsky, MD, PhD, 2019
Modeling Creutzfeldt-Jakob Disease Using Human iPSC-derived Neurons
Center for Regenerative Medicine, Boston University School of Medicine
Dr. Emmanuelle Vire, 2019
Investigating the relevance of blood DNA methylation signals for disease management in CJD
Medical Research Council (MRC) Prion Unit at University College London